S. 3092 · 116th Congress

Expanding Access to Low-Cost Generics Act of 2019

Stage
In committee
Sponsor
Tina Smith
Introduced
2019-12-18
Latest action
2019-12-18 · Introduced in Senate

Summary

Expanding Access to Low-Cost Generics Act of 2019

This bill modifies the 180-day exclusivity period for certain generic drug manufacturers.